Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
174
days
Combining dietary fiber inulin with parathyroid hormone–lowering therapy improves bone remodeling and mechanics in a rat model of Chronic Kidney Disease–Mineral Bone Disorder
Authors
Matthew R. Allen; Corinne E. Metzger; Neal X. Chen; Shruthi Srinivasan; Kalisha O'Neill; Hannah E. Wilson; Karis L. Blacklock; Emily K. Matter; Daniel J. Stephen; Karisa M. Ecker; Ariana Moffitt; Annabel Biruete; Sharon M. MoeShow moreShow less
Affiliations
Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA; Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; Roudebush VA, Indianapolis, Indiana, USA; Department of Nutrition Science, Purdue University, West Lafayette, Indiana, USAShow moreShow less
339
days
Generation of a novel Slc7a9G105R mutant mouse identifies new biomarkers for cystinuria
Authors
Nirmal P. Bhatt; Theresa T.H. Nguyen; Giulia Iacono; Gabriel R. Rodriguez; Connor R.B. Anderson; Andrew Perry; Christopher K. Barlow; Dovile Anderson; Gaetan Burgio; Benjamin J. Marsland; Simon H. Jiang; Aniruddh V. Deshpande; Malcolm R. StarkeyShow moreShow less
Affiliations
Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Bladder and Kidney Health Discovery Program, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia; Monash Genomics and Bioinformatics Platform, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia; Monash Proteomics and Metabolomics Platform, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia; Monash Proteomics and Metabolomics Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia; Department of Genome and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia; Division of Immunology and Infectious Diseases, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia; Centre for Personalized Medicine, John Curtin School of Medical Research, Australian National University and Canberra Health Services, Canberra, Australian Capital Territory, Australia; Department of Nephrology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia; Centre for Kidney Research, The Children’s Hospital at Westmead, University of Sydney, Sydney, New South Wales, Australia; Urology Unit, Department of Surgery, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia; School of Medical Sciences, The University of Sydney, New South Wales, AustraliaShow moreShow less
228
days
Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis
Authors
Muhammad Umaid Rauf; Mattia Riefolo; Ethan Wong; Janet Gilbertson; Aviva Petrie; Steven Law; Yousuf Razvi; Josephine Mansell; Awais Sheikh; Jack Carruthers; Adam Ioannou; Aldostefano Porcari; David Hutt; Dorota Rowczenio; Hawah Wurie; Sriram Ravichandran; Oliver C. Cohen; Jahanzaib Khawaja; Joshua Bomsztyk; Tamer Rezk; Ana Martinez-Naharro; Carol Whelan; Helen J. Lachmann; Ashutosh D. Wechalekar; Philip N. Hawkins; Marianna Fontana; Julian D. GillmoreShow moreShow less
Affiliations
National Amyloidosis Centre, University College London (Royal Free Campus), London, UK; Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Biostatistics Unit, University College London (UCL) Eastman Dental Institute, London, UK; Centre for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, ItalyShow moreShow less
152
days
A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation
Authors
Thomas Drasch; Katharina A. Mayer; Georg A. Böhmig; Aylin Akifova; Fabian Halleck; Klemens Budde; David Rohlfing; Christian Hinze; Malte Kluger; Florian Grahammer; Jan Kowald; Sebastian Baatz; Stefan Reuter; Stephan Kemmner; Tobias Seibt; Mareen Pigorsch; Julia Beck; Kirsten Bornemann-Kolatzki; Ekkehard Schütz; Michael Oellerich; Bernhard Banas; Daniel ZecherShow moreShow less
Affiliations
Department of Nephrology, University Hospital Regensburg, Regensburg, Germany; Department of Medicine III, Medical University of Vienna, Vienna, Austria; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany; III. Department of Medicine and Hamburg Center for Kidney Health, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Division of Nephrology, Department of Endocrinology, Nephrology, and Rheumatology, University of Leipzig Medical Center, Leipzig, Germany; Department of Internal Medicine D, Transplant Nephrology, University of Muenster, Muenster, Germany; Transplant Center, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Chronix Biomedical GmbH, Göttingen, Germany; Insight Molecular Diagnostics, Nashville, Tennessee, USA; Department of Clinical Pharmacology, University Medical Center Göttingen, Göttingen, GermanyShow moreShow less
335
days
Sex-specific shifts in CKD classification using European Kidney Function Consortium (EKFC) as compared to CKD Epidemiology (CKD-EPI) eGFR equations
Authors
Ulla T. Schultheiss; Jakob Möller; Thomas McDonnell; Toralf Melsom; Pascal Schlosser; Matthias Wuttke; Peggy Sekula; Philip A. Kalra; Bjørn O. Eriksen; Maarten W. Taal; Anna Köttgen; Kai-Uwe Eckardt; Elke Schaeffner; Inga SteinbrennerShow moreShow less
Affiliations
Institute of Epidemiology and Prevention, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany; Department of Medicine IV, Nephrology and Primary Care, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany; SYNLAB MVZ Humangenetik Freiburg GmbH, Freiburg, Germany; Donal O’Donoghue Renal Research Centre, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK; Division of Cardiovascular Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK; Metabolic and Renal Research Group, UiT—the Arctic University of Norway, Tromsø, Norway; Section of Nephrology, Department of Medicine, University Hospital of North Norway, Tromsø, Norway; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Centre for Integrative Biological Signaling Studies (CIBSS), University of Freiburg, Freiburg, Germany; University Hospitals of Derby and Burton NHS Trust, Derby, UK; Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany; Department of Nephrology and Medical Intensive Care, Charité—Universitätsmedizin Berlin, Berlin, Germany; Institute of Public Health, Charité—Universitätsmedizin Berlin, Berlin, GermanyShow moreShow less
155
days
Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy
Authors
Peter D. Burbelo; Lilian Howard; Tiffany N. Caza; Dorin-Bogdan Borza; Richard W. Childs; John A. Chiorini; Meryl WaldmanShow moreShow less
Affiliations
Adeno-Associated Virus Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA; Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA; Arkana Laboratories, Little Rock, Arkansas, USA; Department of Microbiology, Immunology and Physiology, Meharry Medical College, Nashville, Tennessee, USA; Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USAShow moreShow less
FAQ
How long does KIDNEY INTERNATIONAL take to review a manuscript?
As of 2026-11-19, CrushSCI has 15 complete review records for KIDNEY INTERNATIONAL. The fastest paper went from submission to acceptance in 52 days (CUBN-AMN pathway loss in chronic benign proteinuria, received 2026-01-27, accepted 2026-03-20); the slowest took 421 days. The average is 227.8 days and the median is 217 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
